The Relationship Between Prostatic Microvessel Density and Different Concentrations of Oestrogen/androgen in Sprague-Dawley Rats

Overview

Journal Eur J Med Res

Publisher Biomed Central

Specialty General Medicine

Date 2022 Jun 7

PMID 35672771

Authors

Bo Wang

Di Pan

Yong Ban

Zhaolin Sun

Ye Tian

Guangheng Luo

Affiliations

Soon will be listed here.

Abstract

Background: Currently, there are relatively few studies on the effects of changes in oestrogen and androgen levels on prostatic microvessel density (MVD). This article aimed to study the changes in prostatic MVD in Sprague-Dawley (SD) rats after castration under the effect of oestrogen/androgen at different concentrations.

Methods: Male SD rats aged 3-4 months were randomly divided into a control group, a castration group, and groups with different concentrations of oestrogen/androgen treatment after castration. Dihydrotestosterone (DHT) and oestradiol (E) were administered daily by subcutaneous injection for one month. All the rats were killed by cervical dislocation after one month, and the serum DHT and E concentrations of the rats in each group were measured by ELISA. Prostate tissue specimens were immunohistochemically stained with monoclonal antibodies against CD34 and factor VIII for MVD.

Results: Compared with the control group, the MVD decreased significantly in the castration group (P < 0.05). When the exogenous E concentration was constant, in general, the MVD of rats in all the groups increased with increasing exogenous DHT concentration. Compared with the castration group, the MVD increased significantly in the E0.05 + DHT0.015 mg/kg, E0.05 + DHT0.05 mg/kg, E0.05 + DHT0.15 mg/kg, E0.05 + DHT0.5 mg/kg, and E0.05 + DHT1.5 mg/kg groups (P < 0.05). In addition, when the exogenous DHT concentration was constant, the MVD increased with increasing exogenous E concentration in all the groups. Among them, compared with the control and castration groups, the MVD increased significantly in the DHT0.15 + E0.015 mg/kg, DHT0.15 + E0.15 mg/kg, and DHT0.15 + E0.5 mg/kg groups (P < 0.05).

Conclusions: Androgens play an important role in the regulation of prostatic MVD in SD rats, and a decrease in DHT concentration can induce a decrease in prostatic MVD. In contrast, prostatic MVD can be increased with increasing DHT concentration. In addition, prostatic MVD can be increased gradually with increasing oestrogen concentration.

Citing Articles

Characterization of prostate macrophage heterogeneity, foam cell markers, and CXCL17 upregulation in a mouse model of steroid hormone imbalance.

Silver S, Tucker K, Vickman R, Lanman N, John Semmes O, Alvarez N Sci Rep. 2024; 14(1):21029.

PMID: 39251671 PMC: 11383972. DOI: 10.1038/s41598-024-71137-4.

Prostate Cancer Microvascular Routes: Exploration and Measurement Strategies.

Grizzi F, Hegazi M, Zanoni M, Vota P, Toia G, Clementi M Life (Basel). 2023; 13(10).

PMID: 37895416 PMC: 10608780. DOI: 10.3390/life13102034.

References

Roberts R, Jacobson D, Rhodes T, Klee G, Leiber M, Jacobsen S . Serum sex hormones and measures of benign prostatic hyperplasia. Prostate. 2004; 61(2):124-31. DOI: 10.1002/pros.20080. View

Foley S, Bailey D . Microvessel density in prostatic hyperplasia. BJU Int. 2000; 85(1):70-3. DOI: 10.1046/j.1464-410x.2000.00322.x. View

Pastore A, Mariani S, Barrese F, Palleschi G, Valentini A, Pacini L . Transurethral resection of prostate and the role of pharmacological treatment with dutasteride in decreasing surgical blood loss. J Endourol. 2012; 27(1):68-70. DOI: 10.1089/end.2012.0231. View

Fagerstrom T, Nyman C, Hahn R . Bipolar transurethral resection of the prostate causes less bleeding than the monopolar technique: a single-centre randomized trial of 202 patients. BJU Int. 2009; 105(11):1560-4. DOI: 10.1111/j.1464-410X.2009.09052.x. View

English H, Drago J, Santen R . Cellular response to androgen depletion and repletion in the rat ventral prostate: autoradiography and morphometric analysis. Prostate. 1985; 7(1):41-51. DOI: 10.1002/pros.2990070106. View

Losordo D, Isner J . Estrogen and angiogenesis: A review. Arterioscler Thromb Vasc Biol. 2001; 21(1):6-12. DOI: 10.1161/01.atv.21.1.6. View

Asiedu B, Anang Y, Nyarko A, Doku D, Amoah B, Santa S . The role of sex steroid hormones in benign prostatic hyperplasia. Aging Male. 2017; 20(1):17-22. DOI: 10.1080/13685538.2016.1272101. View

Wang B, Luo G, Wang Z, Yang B, Xu Y, Sun Z . [Establishment of Rat Prostatitis Model through Induction with Estrogen and Androgen at Different Concentrations]. Sichuan Da Xue Xue Bao Yi Xue Ban. 2021; 52(3):477-484. PMC: 10409200. DOI: 10.12182/20210560305. View

Lecce L, Lam Y, Lindsay L, Yuen S, Simpson P, Handelsman D . Aging impairs VEGF-mediated, androgen-dependent regulation of angiogenesis. Mol Endocrinol. 2014; 28(9):1487-501. PMC: 4154238. DOI: 10.1210/me.2013-1405. View

10.

da Silva B, Lopes-Costa P, Dos Santos A, de Sousa-Junior E, Alencar A, Pires C . Comparison of three vascular endothelial markers in the evaluation of microvessel density in breast cancer. Eur J Gynaecol Oncol. 2009; 30(3):285-8. View

11.

Shih S, DallEra M, Westphal J, Yang J, Sweep C, Gandour-Edwards R . Elements regulating angiogenesis and correlative microvessel density in benign hyperplastic and malignant prostate tissue. Prostate Cancer Prostatic Dis. 2003; 6(2):131-7. DOI: 10.1038/sj.pcan.4500637. View

12.

Holovko S, Savytskyi O . [Efficacy of a high-power laser vaporization in comparison with a monopolar transurethral resection in the treatment of benign prostatic hyperplasia: results of a 6-months follow-up]. Klin Khir. 2013; (7):39-42. View

13.

Jesmin S, Sakuma I, Hattori Y, Kitabatake A . Regulatory molecules for coronary expressions of VEGF and its angiogenic receptor KDR in hypoestrogenic middle-aged female rats. Mol Cell Biochem. 2004; 259(1-2):189-96. DOI: 10.1023/b:mcbi.0000021372.99727.b3. View

14.

Sugie S, Mukai S, Tsukino H, Iwamoto H, Kobayashi T, Toda Y . Effect of dutasteride on microvessel density in benign prostatic hyperplasia. In Vivo. 2014; 28(3):355-9. View

15.

Yatkin E, Bernoulli J, Talvitie E, Santti R . Inflammation and epithelial alterations in rat prostate: impact of the androgen to oestrogen ratio. Int J Androl. 2009; 32(4):399-410. DOI: 10.1111/j.1365-2605.2008.00930.x. View

16.

Gettman M, Bergstralh E, Blute M, Zincke H, Bostwick D . Prediction of patient outcome in pathologic stage T2 adenocarcinoma of the prostate: lack of significance for microvessel density analysis. Urology. 1998; 51(1):79-85. DOI: 10.1016/s0090-4295(97)00464-0. View

17.

Lamping K, Christensen L, Tomanek R . Estrogen therapy induces collateral and microvascular remodeling. Am J Physiol Heart Circ Physiol. 2003; 285(5):H2039-44. DOI: 10.1152/ajpheart.00405.2003. View

18.

Godoy A, Montecinos V, Gray D, Sotomayor P, Yau J, Vethanayagam R . Androgen deprivation induces rapid involution and recovery of human prostate vasculature. Am J Physiol Endocrinol Metab. 2010; 300(2):E263-75. PMC: 3280699. DOI: 10.1152/ajpendo.00210.2010. View

19.

Marciano A, Ieni A, Mauceri R, Oteri G . CD34 and CD105 Microvessels in Resected Bone Specimen May Implicate Wound Healing in MRONJ. Int J Environ Res Public Health. 2021; 18(21). PMC: 8582901. DOI: 10.3390/ijerph182111362. View

20.

Traweek S, Kandalaft P, Mehta P, Battifora H . The human hematopoietic progenitor cell antigen (CD34) in vascular neoplasia. Am J Clin Pathol. 1991; 96(1):25-31. DOI: 10.1093/ajcp/96.1.25. View